Skip to main content

DEME takes delivery of new wind turbine installation vessel Norse Wind

DEME has taken delivery of its new wind turbine installation vessel Norse Wind at the CIMC Raffles Shipyard. Designed to install the next generation of offshore wind turbines, the vessel combines advanced technology and sustainable design features to offer unrivalled installation capability.AttachmentP2025 DEME Delivery Norse Wind 20251016 ENG

Continue reading

Roche presents major advances for its sequencing by expansion technology(1), including a new GUINNESS WORLD RECORD™, at the ASHG conference 2025

Significant progress in bulk RNA sequencing, methylation mapping, multiomics integration, and spatial analyses unlocks research previously out of reach for traditional short read platforms. Leveraging Roche’s SBX technology, Broad Clinical Labs achieved the new GUINNESS WORLD RECORD™ for fastest DNA sequencing technique in under four hours, in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital. Wellcome Sanger Institute joins a growing network of early collaborators using SBX technology, driving new insights in genomics research.Basel, 16 October 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) presented major updates on its innovative sequencing by expansion (SBX) technology at the American Society of Human Genetics (ASHG) 2025 Annual Meeting in Boston, USA. Following its recent unveiling, SBX is already...

Continue reading

Novartis Fabhalta® (iptacopan) meets Phase III primary endpoint, slows kidney function decline in patients with IgA nephropathy (IgAN)

In APPLAUSE-IgAN final analysis, Fabhalta demonstrated statistically significant, clinically meaningful improvement in estimated glomerular filtration rate (eGFR) slope vs. placebo over two years1 eGFR is key marker of kidney function; IgAN is progressive autoimmune kidney disease that leads to kidney failure in many patients1-3  Fabhalta is first and only approved complement inhibitor for adults with IgAN and has potential to delay disease progression4,5  Fabhalta received accelerated approval for reduction of proteinuria in adults with IgAN in US in 2024; data support 2026 submission for traditional FDA approval4,5 Basel, October 16, 2025 – Novartis today announced positive final results from APPLAUSE-IgAN, a Phase III study evaluating Fabhalta® (iptacopan) in adults living with IgA nephropathy (IgAN). Fabhalta, an oral alternative...

Continue reading

Start of construction on Liven’s Virmalise project

Yesterday, preparations for construction began on the Virmalise project developed by Liven Kodu 21 OÜ, a subsidiary of Liven AS (“Liven”). By the end of 2026, a four-story residential building with a private courtyard will be completed at Virmalise 3 in the Uue-Maailma district of Tallinn, offering 28 new homes. The general contractor for the construction works is Bildgren Ehitus OÜ, and the architectural design was created by Liven together with Arhitektuuribüroo Kuup Ruut OÜ. The total cost of the construction works is nearly EUR 5.0 million, plus VAT. As of today, 29% of the 28 homes under construction have been sold. More information about the project can be found on the website virmalise.liven.ee. Joonas JoostLiven AS CFOE-mail: joonas.joost@liven.ee

Continue reading

FG Communities Completes Third Acquisition in Candler, NC

Expanding Our Footprint in a Growing Region CHARLOTTE, N.C., Oct. 15, 2025 (GLOBE NEWSWIRE) — FG Communities, whose mission is to preserve and improve affordable housing by acquiring and operating manufactured housing communities, is excited to announce its most recent acquisition in Candler, NC. This community, which contains 51 homesites on over 8 acres, marks FG Communities’ third acquisition in Candler, NC, located just west of Asheville. The city’s downtown area, known for its art museums, shopping, and vibrant music scene, is only 10 miles from the community. The Blue Ridge Parkway, famous for hiking trails and scenic overlooks, can be reached in under a half hour. Asheville and the surrounding region have experienced strong population growth in recent years, driving steady increases in real estate values. The Candler manufactured...

Continue reading

Apollo Names Eiji Ueda Head of Asia Pacific as Firm Marks 20 Years in Region

Appointment opens a new chapter in Apollo’s next phase of growth: expanding capital, wealth and retirement solutions across the region TOKYO and NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced Mr. Eiji Ueda has been named a Partner and Head of Asia Pacific, succeeding Matt Michelini. Michelini, who has spearheaded Apollo’s rapid expansion across the region since his appointment in 2022, will remain in region to oversee Ueda’s transition before assuming broader leadership responsibilities with the firm next year. Ueda joins Apollo with demonstrated investment expertise and a nuanced understanding of Asia’s evolving needs. He most recently served as Chief Investment Officer of Japan’s Government Pension Investment Fund (GPIF), one of the largest institutional investors globally, where he led a strategic...

Continue reading

Great Southern Bancorp, Inc. Reports Preliminary Third Quarter Earnings of $1.56 Per Diluted Common Share

Preliminary Financial Results and Business Update for the Quarter Ended September 30, 2025 SPRINGFIELD, Mo., Oct. 15, 2025 (GLOBE NEWSWIRE) — Great Southern Bancorp, Inc. (the “Company”) (NASDAQ:GSBC), the holding company for Great Southern Bank (the “Bank”), today reported that preliminary earnings for the three months ended September 30, 2025, were $1.56 per diluted common share ($17.8 million net income) compared to $1.41 per diluted common share ($16.5 million net income) for the three months ended September 30, 2024. For the quarter ended September 30, 2025, annualized return on average common equity was 11.30%, annualized return on average assets was 1.23%, and annualized net interest margin was 3.72%, compared to 11.10%, 1.11% and 3.42%, respectively, for the quarter ended September 30, 2024. Third Quarter 2025 Key Results:Net...

Continue reading

High-grade copper and gold intersections extend known mineralisation at FireFly’s Green Bay by 650m

The furthest intersection returns 49m at 6.1% CuEq1 and remains open at depth; These results will form part of the Mineral Resource Estimate update set for this quarter KEY POINTSDrilling from the end of the Ming mine exploration drive has extended the known mineralisation by 430m beyond previous drilling and more than 650m beyond the October 2024 Mineral Resource Estimate The strength of the mineralisation (i.e. the combination of grade and width) appears to be increasing at depth with the furthest hole returning one of the best intersections drilled in the deposit to date:49.0m @ 6.1% copper equivalent (CuEq)1 (4.9% Cu & 1.3g/t Au) in hole MUG25-202 (~39.2m true thickness), including14.3m @ 13.7% CuEq (10.6% Cu & 3.2% Au)Importantly, these drillholes confirm that the previously reported ~700m long downhole electromagnetic...

Continue reading

CORRECTION: Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital

Initial Conversion Price of $5.00 Per Share Representing a 280% Premium Over the Company’s Recent Closing Price of $1.78 MELBOURNE, Australia, Oct. 15, 2025 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (“Propanc” or the “Company”) is pleased to announce it has entered into a strategic financing agreement of up to $100 million with Hexstone Capital LLC (“Hexstone”), a family office that has invested in a significant number of Digital Asset Treasury (DAT) companies across a range of digital assets including BTC, ETH, SOL, DOGE, ATH, OG, and INJ. “We are delighted to enter into this strategically important transaction with Hexstone Capital,” said James Nathanielsz, Chief Executive Officer of Propanc. “This financing will allow us to accelerate the development of our clinical pipeline and leverage...

Continue reading

Dragonfly Energy Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

RENO, Nev., Oct. 15, 2025 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), an industry leader in energy storage and battery technology, today announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase shares of its common stock. In addition, Dragonfly Energy expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the securities to be sold in the proposed offering at the public offering price for the common stock, less underwriting discounts and commissions. All shares of common stock and pre-funded warrants are being offered by Dragonfly Energy. The proposed offering is subject to market and other conditions, and there...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.